News | Latest Breaking News Stories & Headlines

Ireland is becoming an increasingly critical global hub for AstraZeneca operations, the company has said

AstraZeneca's Alexion to invest €65m in Irish operation

AstraZeneca's Rare Disease group, Alexion, is investing €65m in new and enhanced capabilities across its sites in College Park in Blanchardstown and Monksland Industrial Park in Athlone.

Business • 24 Jun 22

The merger with Alexion will beef up straZeneca's line of cancer medicines

UK nod paves way for AstraZeneca-Alexion deal to close

AstraZeneca's $39 billion buyout of US-based rare diseases business Alexion is expected to close next week as Britain's competition watchdog cleared the deal today.

Business • 14 Jul 21

Dunoyer will replace Ludwig Hantson as boss of United States-based Alexion on completion of the agreed deal

AstraZeneca moves finance chief Dunoyer to head Alexion

AstraZeneca will move finance chief Marc Dunoyer to head newly acquired rare diseases business Alexion, using the $39 billion takeover as an opportunity to freshen up a management team that had been in place for eight years.

Business • 04 Jun 21

Soliris drug is one of the most expensive in the world

Patients with rare disorder to get €430,000 drug

One of the world's most expensive drugs is to be provided to more patients suffering from a life-threatening blood disorder even though the manufacturers have not reduced the price.

News • 04 Feb 15